ESOPHAGEAL ADENOCARCINOMA
Clinical trials for ESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer-Killing virus injected into tumors before surgery: a new hope?
Disease control Not yet recruitingThis study tests whether injecting a virus called RP2 directly into stomach and esophageal tumors, combined with standard FLOT chemotherapy, is safe and works better than chemotherapy alone before surgery. About 34 people with stage II or higher non-metastatic gastroesophageal ca…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Freezing tumors before chemo: new hope for esophageal cancer?
Disease control Not yet recruitingThis study tests whether freezing cancer cells with liquid nitrogen before chemotherapy can improve outcomes for people with advanced esophageal cancer. About 40 adults will be randomly assigned to receive either the freezing treatment plus chemotherapy or chemotherapy alone. The…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC
-
Could a tiny dose of radiation reboot immunotherapy for tough esophageal cancers?
Disease control Not yet recruitingThis study tests whether a single, low dose of radiation to all visible tumors can help immunotherapy start working again in people with advanced esophageal cancer that has stopped responding to standard chemo-immunotherapy. About 32 adults will receive the radiation and then con…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
Could a fungal drug stop esophageal cancer before it starts?
Prevention Not yet recruitingThis study tests whether adding the antifungal drug itraconazole to standard ablation therapy can prevent esophageal cancer in people with high-risk Barrett's esophagus. About 64 participants will receive either itraconazole or a placebo alongside their usual endoscopic ablation.…
Matched conditions: ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 15, 2026 18:57 UTC